These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
83. [Value of cerebral spinal fluid measurement of hypocretin-1 in the diagnosis of Chinese patients with narcolepsy]. Dong XS; Li YQ; Li J; An HY; Liu YN; Zhang XZ; An P; Yan H; Zhao L; Li QH; Yang BX; Gao ZC; Han F Zhonghua Yi Xue Za Zhi; 2013 Jul; 93(26):2038-42. PubMed ID: 24169281 [TBL] [Abstract][Full Text] [Related]
84. Multiple sleep latency test may be not sensitive in obstructive sleep apnea with comorbid narcolepsy revealed by low cerebrospinal fluid orexin levels. Liguori C; Izzi F; Romigi A; Mercuri NB; Albanese M; Marciani MG; Placidi F Sleep Med; 2014 Sep; 15(9):1171. PubMed ID: 24980064 [No Abstract] [Full Text] [Related]
85. Isolated mediotegmental lesion causing narcolepsy and rapid eye movement sleep behaviour disorder: a case evidencing a common pathway in narcolepsy and rapid eye movement sleep behaviour disorder. Mathis J; Hess CW; Bassetti C J Neurol Neurosurg Psychiatry; 2007 Apr; 78(4):427-9. PubMed ID: 17369596 [TBL] [Abstract][Full Text] [Related]
86. Orexin A (hypocretin-1) levels are not reduced while cocaine/amphetamine regulated transcript levels are increased in the cerebrospinal fluid of patients with multiple sclerosis: no correlation with fatigue and sleepiness. Constantinescu CS; Niepel G; Patterson M; Judd A; Braitch M; Fahey AJ; Harikrishnan S; Edwards LJ; Tench CR; Bennett GW; Ghatei M J Neurol Sci; 2011 Aug; 307(1-2):127-31. PubMed ID: 21605873 [TBL] [Abstract][Full Text] [Related]
87. Locomotor-dependent and -independent components to hypocretin-1 (orexin A) regulation in sleep-wake consolidating monkeys. Zeitzer JM; Buckmaster CL; Lyons DM; Mignot E J Physiol; 2004 Jun; 557(Pt 3):1045-53. PubMed ID: 15107479 [TBL] [Abstract][Full Text] [Related]
88. CSF levels of hypocretin-1 (orexin-A) peak during early infancy in humans. Aran A; Shors I; Lin L; Mignot E; Schimmel MS Sleep; 2012 Feb; 35(2):187-91. PubMed ID: 22294808 [TBL] [Abstract][Full Text] [Related]
89. Niemann-Pick disease type C: cataplexy and hypocretin in cerebrospinal fluid. Oyama K; Takahashi T; Shoji Y; Oyamada M; Noguchi A; Tamura H; Takada G; Kanbayashi T Tohoku J Exp Med; 2006 Jul; 209(3):263-7. PubMed ID: 16778374 [TBL] [Abstract][Full Text] [Related]
90. Exploring the presence of narcolepsy in patients with schizophrenia. Sansa G; Gavaldà A; Gaig C; Monreal J; Ercilla G; Casamitjana R; Ribera G; Iranzo A; Santamaria J BMC Psychiatry; 2016 Jun; 16():177. PubMed ID: 27245445 [TBL] [Abstract][Full Text] [Related]
91. Cerebrospinal fluid hypocretin levels are normal in idiopathic REM sleep behaviour disorder. Anderson KN; Vincent A; Smith IE; Shneerson JM Eur J Neurol; 2010 Aug; 17(8):1105-7. PubMed ID: 20113337 [TBL] [Abstract][Full Text] [Related]
92. CSF-profile and hypocretin levels in children with narcolepsy type 1 and 2. Josler M; El Naggar I; Bertolini A; Kutz P; Roll C; Wendel EM; Schlüter B; Hahn A; Siegert S; Hackenberg A; Zuberi SM; Otto M; Rostásy K Eur J Paediatr Neurol; 2024 Aug; 53():1-7. PubMed ID: 39226768 [TBL] [Abstract][Full Text] [Related]
93. Hypersomnia and low CSF hypocretin-1 (orexin-A) concentration in a patient with multiple sclerosis showing bilateral hypothalamic lesions. Kato T; Kanbayashi T; Yamamoto K; Nakano T; Shimizu T; Hashimoto T; Ikeda S Intern Med; 2003 Aug; 42(8):743-5. PubMed ID: 12924505 [TBL] [Abstract][Full Text] [Related]
94. Hypocretin measurement in an Icelandic foal with narcolepsy. Bathen-Nöthen A; Heider C; Fernandez AJ; Beineke A; Sewell AC; Otto M; Tipold A J Vet Intern Med; 2009; 23(6):1299-302. PubMed ID: 19909431 [No Abstract] [Full Text] [Related]
95. Ventricular cerebrospinal fluid hypocretin-1 inversely correlates with glucose levels in cerebrospinal fluid and serum from patients with neurological injuries. Doherty MJ; Watson NF; Hallam DK; Chandler WL; Longstreth WT Neurocrit Care; 2005; 3(3):230-3. PubMed ID: 16377834 [TBL] [Abstract][Full Text] [Related]
96. Increased CSF hypocretin-1 (orexin-A) in restless legs syndrome. Allen RP; Mignot E; Ripley B; Nishino S; Earley CJ Neurology; 2002 Aug; 59(4):639-41. PubMed ID: 12196669 [TBL] [Abstract][Full Text] [Related]
97. Pre-treatment of blood samples reveal normal blood hypocretin/orexin signal in narcolepsy type 1. Ægidius HM; Kruse L; Christensen GL; Lorentzen MP; Jørgensen NR; Moresco M; Pizza F; Plazzi G; Jennum PJ; Kornum BR Brain Commun; 2021; 3(2):fcab050. PubMed ID: 33977264 [TBL] [Abstract][Full Text] [Related]
98. Decreased CSF hypocretin-1 (orexin-A) after acute haemorrhagic brain injury. Rejdak K; Petzold A; Lin L; Smith M; Kitchen N; Thompson EJ J Neurol Neurosurg Psychiatry; 2005 Apr; 76(4):597-8. PubMed ID: 15774458 [No Abstract] [Full Text] [Related]
99. CSF hypocretin levels are normal in Huntington's disease patients. Gaus SE; Lin L; Mignot E Sleep; 2005 Dec; 28(12):1607-8. PubMed ID: 16408421 [No Abstract] [Full Text] [Related]
100. "Oh My Sleeping Child" … Narcolepsy Type 1 in a 22-Month-Old Boy. Giourgas B; Morgan A; Bhatia S Child Neurol Open; 2024; 11():2329048X231225916. PubMed ID: 38766557 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]